Erratum to “An update on clinical presentation and responses to therapy of patients with hereditary hypophosphatemic rickets with hypercalciuria (HHRH).” Kidney International 2023;105:1058–1076 (Kidney International (2024) 105(5) (1058–1076), (S0085253824000978), (10.1016/j.kint.2024.01.031))

Zewu Zhu, Bryan Bo-Ran Ho, Alyssa Chen, James Amrhein, Andreea Apetrei, Thomas Oliver Carpenter, Marise Lazaretti-Castro, Juan Manuel Colazo, Kathryn McCrystal Dahir, Michaela Geßner, Evgenia Gurevich, Cathrine Alsaker Heier, Jill Hickman Simmons, Tracy Earl Hunley, Bernd Hoppe, Christina Jacobsen, Anne Kouri, Nina Ma, Sachin Majumdar, Arnaud MolinNatalie Nokoff, Susan M. Ott, Helena Gil Peña, Fernando Santos, Peter Tebben, Lisa Swartz Topor, Yanhong Deng, Clemens Bergwitz

Research output: Contribution to journalComment/debatepeer-review

Abstract

The publisher regrets that the definition of het-post (post-treatment levels of het carriers) was not included in the legends of Figure 3 and Supplementary Figure S3, and that descriptions of upper limit (%UL) and/or z-score were not included in the legends of Supplementary Figures S2–S4, S6, S8, S9, S11, S12, and S14 in the XML version of the article. This article has been corrected online. The publisher would like to apologize for any inconvenience caused.

Original languageEnglish (US)
Pages (from-to)159
Number of pages1
JournalKidney international
Volume106
Issue number1
DOIs
StatePublished - Jul 2024

Bibliographical note

Publisher Copyright:
© 2024 International Society of Nephrology

Fingerprint

Dive into the research topics of 'Erratum to “An update on clinical presentation and responses to therapy of patients with hereditary hypophosphatemic rickets with hypercalciuria (HHRH).” Kidney International 2023;105:1058–1076 (Kidney International (2024) 105(5) (1058–1076), (S0085253824000978), (10.1016/j.kint.2024.01.031))'. Together they form a unique fingerprint.

Cite this